首页 > 最新文献

Recenti progressi in medicina最新文献

英文 中文
Recensioni.
“Il primo libro di sociologia della salute”.
评论:"第一本关于健康社会学的书"。
Q3 Medicine Pub Date : 2024-10-01 DOI: 10.1701/4357.43473
{"title":"Recensioni.<br>“Il primo libro di sociologia della salute”.","authors":"","doi":"10.1701/4357.43473","DOIUrl":"https://doi.org/10.1701/4357.43473","url":null,"abstract":"","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":"115 10","pages":"492"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142506803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sacituzumab govitecan nel trattamento delle pazienti anziane con carcinoma mammario metastatico. 萨妥珠单抗戈维替康治疗老年转移性乳腺癌患者。
Q3 Medicine Pub Date : 2024-10-01 DOI: 10.1701/4357.43482
Marta Perachino, Matteo Lambertini
{"title":"Sacituzumab govitecan nel trattamento delle pazienti anziane con carcinoma mammario metastatico.","authors":"Marta Perachino, Matteo Lambertini","doi":"10.1701/4357.43482","DOIUrl":"https://doi.org/10.1701/4357.43482","url":null,"abstract":"","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":"115 10","pages":"65e-67e"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142506805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Twelve tips for medical teachers to facilitate effective discussion among students to engage in reflective interpretation of Museum Arts [医学教师促进学生有效讨论以参与博物馆艺术反思性阐释的十二条建议]。
Q3 Medicine Pub Date : 2024-10-01 DOI: 10.1701/4357.43463
Krishna Mohan Surapaneni

Integrating arts and humanities into medical education is a pragmatic approach that significantly enriches students’ learning experiences by enhancing their observational, interpretative, and empathetic skills. Engaging students in thoughtful dialogue become crucial at it not only enriches their understanding of human experiences and cultural contexts but also sharpens their communication skills – essential for effective patient interactions and collaborative healthcare environments. This article outlines twelve essential tips for medical teachers aimed at effectively facilitating discussions among students within the context of museum arts. These strategies are carefully designed to create a safe and inclusive learning environment, promote active and equitable participation, and encourage deep, reflective interpretation of artworks. By implementing these tips, educators can not only foster a more conducive educational landscape but also significantly enhance their own teaching practices by pushing the boundaries of traditional medical curricula with new ways to integrate empathy, critical thinking, and cultural awareness.

摘要将艺术和人文学科融入医学教育是一种务实的方法,通过提高学生的观察、解释和移情技能,极大地丰富了他们的学习体验。让学生参与深思熟虑的对话变得至关重要,因为这不仅能丰富他们对人类经历和文化背景的理解,还能提高他们的沟通技巧,这对于与患者有效互动和协作式医疗环境至关重要。本文概述了医学教师在博物馆艺术背景下有效促进学生讨论的十二条基本建议。这些策略经过精心设计,旨在营造一个安全、包容的学习环境,促进积极、平等的参与,并鼓励对艺术作品进行深入、反思性的解读。通过实施这些建议,教育工作者不仅可以营造一个更具支持性的教育环境,还能极大地改进自身的教学实践,通过整合同理心、批判性思维和文化意识的新方法来突破传统医学课程的界限。
{"title":"Twelve tips for medical teachers to facilitate effective discussion among students to engage in reflective interpretation of Museum Arts","authors":"Krishna Mohan Surapaneni","doi":"10.1701/4357.43463","DOIUrl":"10.1701/4357.43463","url":null,"abstract":"<p><p>Integrating arts and humanities into medical education is a pragmatic approach that significantly enriches students’ learning experiences by enhancing their observational, interpretative, and empathetic skills. Engaging students in thoughtful dialogue become crucial at it not only enriches their understanding of human experiences and cultural contexts but also sharpens their communication skills – essential for effective patient interactions and collaborative healthcare environments. This article outlines twelve essential tips for medical teachers aimed at effectively facilitating discussions among students within the context of museum arts. These strategies are carefully designed to create a safe and inclusive learning environment, promote active and equitable participation, and encourage deep, reflective interpretation of artworks. By implementing these tips, educators can not only foster a more conducive educational landscape but also significantly enhance their own teaching practices by pushing the boundaries of traditional medical curricula with new ways to integrate empathy, critical thinking, and cultural awareness.</p>","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":"115 10","pages":"455-460"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142506780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Efficacy of topical tirbanibulin in treating actinic keratosis.] [外用替巴尼布林治疗 2 级光化性角化病的疗效]。
Q3 Medicine Pub Date : 2024-10-01 DOI: 10.1701/4357.43477
Alessia Villani

Actinic keratoses (AK) are common precancerous lesions usually arising on chronic sun-exposed areas. Field of cancerization (FC) is a chronically UV-exposed area in which subclinical multifocal AKs are found. Therapeutic choice is mainly made according to the Olsen grade of AKs. We report the case of a 76-year-old man with numerous AKs of the face and scalp. The patient had undergone numerous topical physical and medical therapies with poor results. On the left cheek, grade I and grade II AKs were found in a large FC, so he was prescribed topical therapy with tirbanibulin 1% ointment. After 10 days erythema and crusts were objectified and a burning sensation was reported on the area of application and on surrounding areas. At 8 weeks follow-up, the patient had total resolution of disease and no residual local side effects. Although tirbanibulin 1% ointment has indication for type I AKs of face and scalp, this case reported its efficacy and benefit also on type II AKs, demonstrating safety and a minimal and manageable degree of discomfort caused to the patient. Therefore, it fits fully among the treatments of grade I AKs but numerous still may be its indications as demonstrated in our case, where efficacy, safety and compliance were combined.

日光性角化病(AK)是一种常见的癌前病变,通常发生在长期暴露于阳光的部位。癌变区(FC)是指长期暴露于紫外线下的区域,在这些区域会发现亚临床多灶性 AK。治疗方法主要根据 AK 的奥尔森分级来选择。我们报告了一例 76 岁男性患者的病例,他的面部和头皮有多处 AK。患者曾多次接受局部物理和药物治疗,但效果不佳。在左侧脸颊上,发现了大面积的 I 级和 II 级 AK,因此他被处方使用 1%替班布林软膏进行局部治疗。10 天后,患者出现红斑和结痂,涂药部位和周围有灼烧感。在 8 周的随访中,患者的病情完全缓解,局部也没有残留的副作用。虽然 1%替班布林软膏适用于面部和头皮的 I 型 AK,但本病例报告了它对 II 型 AK 的疗效和益处,并证明了它的安全性以及对患者造成的最小和可控程度的不适。因此,它完全符合 I 型 AK 的治疗方法,但正如我们的病例所示,它的适应症仍然很多,疗效、安全性和依从性都很好。
{"title":"[Efficacy of topical tirbanibulin in treating actinic keratosis.]","authors":"Alessia Villani","doi":"10.1701/4357.43477","DOIUrl":"10.1701/4357.43477","url":null,"abstract":"<p><p>Actinic keratoses (AK) are common precancerous lesions usually arising on chronic sun-exposed areas. Field of cancerization (FC) is a chronically UV-exposed area in which subclinical multifocal AKs are found. Therapeutic choice is mainly made according to the Olsen grade of AKs. We report the case of a 76-year-old man with numerous AKs of the face and scalp. The patient had undergone numerous topical physical and medical therapies with poor results. On the left cheek, grade I and grade II AKs were found in a large FC, so he was prescribed topical therapy with tirbanibulin 1% ointment. After 10 days erythema and crusts were objectified and a burning sensation was reported on the area of application and on surrounding areas. At 8 weeks follow-up, the patient had total resolution of disease and no residual local side effects. Although tirbanibulin 1% ointment has indication for type I AKs of face and scalp, this case reported its efficacy and benefit also on type II AKs, demonstrating safety and a minimal and manageable degree of discomfort caused to the patient. Therefore, it fits fully among the treatments of grade I AKs but numerous still may be its indications as demonstrated in our case, where efficacy, safety and compliance were combined.</p>","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":"115 10","pages":"46e-47e"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142506782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ritratto di Luciano Orsi: al servizio delle persone malate. 卢西亚诺-奥尔西(Luciano Orsi)肖像:为病人服务。
Q3 Medicine Pub Date : 2024-09-01 DOI: 10.1701/4334.43187
{"title":"Ritratto di Luciano Orsi: al servizio delle persone malate.","authors":"","doi":"10.1701/4334.43187","DOIUrl":"https://doi.org/10.1701/4334.43187","url":null,"abstract":"","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":"115 9","pages":"429-430"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142294076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Anticoagulant therapy in venous thromboembolism and bleeding risk: focus on the use of predictive scores.] [静脉血栓栓塞症的抗凝治疗与出血风险:重点关注预测评分的使用。]
Q3 Medicine Pub Date : 2024-09-01 DOI: 10.1701/4334.43177
Laura M Cavagna, Mario Bazzan

The standard treatment for venous thromboembolism (Vte) is anticoagulation. Drug selection and treatment duration will depend on the clinical presentation, the existence of provoking factors, bleeding risk, and the patient's preferences. Anticoagulation therapy is indicated for 3-6 months in all patients with acute Vte but may be extended, even indefinitely in some cases. The most severe side effect of anticoagulation is bleeding, with the highest risk occurring during the 1st months of therapy. Balancing the risk of bleeding and the risk of recurrence in patients with Vte remain a major issue. There are, currently, no simple and validated predictive scores to estimate the long-term bleeding risk in patients undergoing anticoagulant treatment and to safely select those patients with higher bleeding risk. In this review we will examine some of these scores, including the RIETE scores, the HAS-BLED SCORE, the VTE-BLEED score, the VTE- PREDICT and the ACCP guidelines and the timing for their application in the patient's population treated for Vte as well as the initial and long-term management and evaluation of thromboembolic disease.

静脉血栓栓塞症(Vte)的标准治疗方法是抗凝。药物选择和治疗时间取决于临床表现、是否存在诱发因素、出血风险以及患者的偏好。抗凝治疗适用于所有急性 Vte 患者,疗程为 3-6 个月,但也可延长,甚至在某些情况下无限期延长。抗凝治疗最严重的副作用是出血,最高风险出现在治疗的最初几个月。如何平衡 Vte 患者的出血风险和复发风险仍是一个重要问题。目前还没有简单有效的预测评分来估计接受抗凝治疗的患者的长期出血风险,并安全地选择出血风险较高的患者。在本综述中,我们将研究其中的一些评分,包括 RIETE 评分、HAS-BLED 评分、VTE-BLEED 评分、VTE- PREDICT 和 ACCP 指南,以及在接受 VTE 治疗的患者群体中应用这些评分的时机,以及血栓栓塞性疾病的初始和长期管理与评估。
{"title":"[Anticoagulant therapy in venous thromboembolism and bleeding risk: focus on the use of predictive scores.]","authors":"Laura M Cavagna, Mario Bazzan","doi":"10.1701/4334.43177","DOIUrl":"https://doi.org/10.1701/4334.43177","url":null,"abstract":"<p><p>The standard treatment for venous thromboembolism (Vte) is anticoagulation. Drug selection and treatment duration will depend on the clinical presentation, the existence of provoking factors, bleeding risk, and the patient's preferences. Anticoagulation therapy is indicated for 3-6 months in all patients with acute Vte but may be extended, even indefinitely in some cases. The most severe side effect of anticoagulation is bleeding, with the highest risk occurring during the 1st months of therapy. Balancing the risk of bleeding and the risk of recurrence in patients with Vte remain a major issue. There are, currently, no simple and validated predictive scores to estimate the long-term bleeding risk in patients undergoing anticoagulant treatment and to safely select those patients with higher bleeding risk. In this review we will examine some of these scores, including the RIETE scores, the HAS-BLED SCORE, the VTE-BLEED score, the VTE- PREDICT and the ACCP guidelines and the timing for their application in the patient's population treated for Vte as well as the initial and long-term management and evaluation of thromboembolic disease.</p>","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":"115 9","pages":"389-396"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142294060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Is there a correlation between increasing hospital falls and Covid-19 infection? Retrospective study on the entire hospital population.] [医院跌倒的增加与 Covid-19 感染之间有关联吗?对所有住院病人的回顾性研究]。
Q3 Medicine Pub Date : 2024-09-01 DOI: 10.1701/4334.43183
Federica Gonella, Antonio Valenti, Oscar Testa, Andrea Ricotti, Stefano Passi, Barbara Mitola

Introduction Falls are the second leading cause of accidental or unintentional death worldwide. In hospital falls represent a relevant health problem, in particular after their increasing since Covid year 2020. The aim of this study is to evaluate correlation between falls and Covid infection.

Methods: Risk Management Unit at Mauriziano hospital analyzed in the present observational study possible correlation with Covid Pandemic and falls risk factors, through comparison of patients falls occurred during year 2021 in Covid and no-Covid wards. The primary outcome of the study is the evaluation of relationship between falls and Covid infection. The secondary outcome is identification of falls risk factors.

Results: No direct correlation between falls and Covid-19 infection was found. Among falls risk factors, the most interesting emerged is the fall itself that enhances the risk of relapse.

Discussion: Increasing in patients falls since 2020 could be affected indirectly by strong hospital organization modifications during Covid pandemic.

导言:跌倒是导致全球意外或无意死亡的第二大原因。医院中的跌倒是一个相关的健康问题,尤其是自 2020 年以来,跌倒的发生率不断上升。本研究旨在评估跌倒与Covid感染之间的相关性:毛里齐亚诺医院风险管理部门在本观察性研究中通过比较 2021 年期间在感染 Covid 和未感染 Covid 病房中发生跌倒的患者,分析了 Covid 大流行与跌倒风险因素之间可能存在的相关性。研究的主要结果是评估跌倒与 Covid 感染之间的关系。次要结果是确定跌倒风险因素:结果:未发现跌倒与 Covid-19 感染之间存在直接关联。在跌倒风险因素中,最值得关注的是跌倒本身会增加复发风险:讨论:自 2020 年以来,患者跌倒的增加可能间接受到 Covid 大流行期间医院组织结构调整的影响。
{"title":"[Is there a correlation between increasing hospital falls and Covid-19 infection? Retrospective study on the entire hospital population.]","authors":"Federica Gonella, Antonio Valenti, Oscar Testa, Andrea Ricotti, Stefano Passi, Barbara Mitola","doi":"10.1701/4334.43183","DOIUrl":"10.1701/4334.43183","url":null,"abstract":"<p><p>Introduction Falls are the second leading cause of accidental or unintentional death worldwide. In hospital falls represent a relevant health problem, in particular after their increasing since Covid year 2020. The aim of this study is to evaluate correlation between falls and Covid infection.</p><p><strong>Methods: </strong>Risk Management Unit at Mauriziano hospital analyzed in the present observational study possible correlation with Covid Pandemic and falls risk factors, through comparison of patients falls occurred during year 2021 in Covid and no-Covid wards. The primary outcome of the study is the evaluation of relationship between falls and Covid infection. The secondary outcome is identification of falls risk factors.</p><p><strong>Results: </strong>No direct correlation between falls and Covid-19 infection was found. Among falls risk factors, the most interesting emerged is the fall itself that enhances the risk of relapse.</p><p><strong>Discussion: </strong>Increasing in patients falls since 2020 could be affected indirectly by strong hospital organization modifications during Covid pandemic.</p>","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":"115 9","pages":"415-419"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142294062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
per conoscere, per riflettere, per costruire reti. 学习、反思、建立网络。
Q3 Medicine Pub Date : 2024-09-01 DOI: 10.1701/4334.43174
{"title":"per conoscere, per riflettere, per costruire reti.","authors":"","doi":"10.1701/4334.43174","DOIUrl":"https://doi.org/10.1701/4334.43174","url":null,"abstract":"","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":"115 9","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142294075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In ricordo di Robin Warren. 悼念罗宾-沃伦
Q3 Medicine Pub Date : 2024-09-01 DOI: 10.1701/4334.43186
{"title":"In ricordo di Robin Warren.","authors":"","doi":"10.1701/4334.43186","DOIUrl":"https://doi.org/10.1701/4334.43186","url":null,"abstract":"","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":"115 9","pages":"428"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142294073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Le cadute degli anziani si possono prevenire? 老年人跌倒可以预防吗?
Q3 Medicine Pub Date : 2024-09-01 DOI: 10.1701/4334.43189
{"title":"Le cadute degli anziani si possono prevenire?","authors":"","doi":"10.1701/4334.43189","DOIUrl":"https://doi.org/10.1701/4334.43189","url":null,"abstract":"","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":"115 9","pages":"432-433"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142294074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Recenti progressi in medicina
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1